Objective
Sleep apnea (SA) is not just a disease anymore, it is an epidemic affecting more than 500 million people globally. The number of SA patients is increasing rapidly, causing cardiovascular diseases, neurocognitive dysfunction, daytime sleepiness, motor vehicle accidents, etc.
SA is treatable, but the screening and care is not accessible for most people. Still, over 80% of SA-suffering patients are undiagnosed.
Currently, most of the SA diagnostics and therapy is based on complex and stationary technology, available only at clinical settings. Also, the current prevailing methods are invasive, expensive and unreliable. Waiting lists are long, nearly 40% of performed analysis fail and when once diagnosed, patients tend to ditch the treatment soon.
Nukute has a solution. We introduce a telemedicine ready technology that exceeds the current state-of-the-art technologies in analysis reliability, cost, therapy functions and user comfort. It is an excellent addition to expensive, stationary and error-prone polysomnography analysis and enables to extend SA screening service to wider patients´ audiences for 90% lower cost.
Our technology combines sensitive microphones and gravity-meters with advanced diagnostics software to identify and predict upcoming SA events. Our unique collar device can diagnose different types of sleep apnea by monitoring the patient´s breathing quality and the respiratory rate and profile. The integrated Therapy function is based on body conditioning. It sends small electric pulses to stimulate the throat muscles when apnea or snoring occurs, without waking up the patient. The HW is integrated with applications running on a smartphone, tablet or laptop.
The technology is already tested successfully against clinical equipment in Finnish hospitals. As a direct result of the project, Nukute will finalise the technology, ensure market clearance in EU and USA and are ready to start market introduction with Screening device from 2018.
Fields of science (EuroSciVoc)
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.
- medical and health sciences clinical medicine psychiatry sleep disorders
- medical and health sciences clinical medicine pneumology asthma
- medical and health sciences clinical medicine endocrinology diabetes
- medical and health sciences clinical medicine cardiology cardiovascular diseases
- medical and health sciences basic medicine neurology stroke
You need to log in or register to use this function
We are sorry... an unexpected error occurred during execution.
You need to be authenticated. Your session might have expired.
Thank you for your feedback. You will soon receive an email to confirm the submission. If you have selected to be notified about the reporting status, you will also be contacted when the reporting status will change.
Programme(s)
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
-
H2020-EU.2.1.1. - INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies - Information and Communication Technologies (ICT)
MAIN PROGRAMME
See all projects funded under this programme -
H2020-EU.2.3.1. - Mainstreaming SME support, especially through a dedicated instrument
See all projects funded under this programme
Topic(s)
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Funding Scheme
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
SME-2 - SME instrument phase 2
See all projects funded under this funding scheme
Call for proposal
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
(opens in new window) H2020-SMEInst-2016-2017
See all projects funded under this callCoordinator
Net EU financial contribution. The sum of money that the participant receives, deducted by the EU contribution to its linked third party. It considers the distribution of the EU financial contribution between direct beneficiaries of the project and other types of participants, like third-party participants.
90220 OULU
Finland
The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.
The total costs incurred by this organisation to participate in the project, including direct and indirect costs. This amount is a subset of the overall project budget.